In our own samples, TET1 expression was clearly downregulated in 17 primary thyroid cancers compared to their paired noncancerous tissues by qRT-PCR and immunohistochemistry (IHC) assays (Supplementary Fig. 1A, B). Here, TET1 is linked to thyroid gland carcinoma.